HLS Trademark

Trademark Overview


On Wednesday, March 2, 2016, a trademark application was filed for HLS with the United States Patent and Trademark Office. The USPTO has given the HLS trademark a serial number of 86925652. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2019. This trademark is owned by HLS Therapeutics Inc.. The HLS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune disease...

Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals
hls

General Information


Serial Number86925652
Word MarkHLS
Filing DateWednesday, March 2, 2016
Status700 - REGISTERED
Status DateTuesday, July 9, 2019
Registration Number5796691
Registration DateTuesday, July 9, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements


Description of MarkThe mark consists of a stylized oak tree with the letters "HLS" underneath it.
Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 7, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 19, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHLS Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W6L2
CA

Party NameHLS Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W6L2
CA

Party NameHLS Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W6L2
CA

Trademark Events


Event DateEvent Description
Friday, June 17, 2016NON-FINAL ACTION E-MAILED
Saturday, March 5, 2016NEW APPLICATION ENTERED
Monday, March 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 8, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 15, 2016ASSIGNED TO EXAMINER
Thursday, June 16, 2016ASSIGNED TO EXAMINER
Friday, June 17, 2016NON-FINAL ACTION WRITTEN
Friday, June 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 21, 2017SUSPENSION INQUIRY WRITTEN
Thursday, December 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017ASSIGNED TO LIE
Thursday, January 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2017SUSPENSION LETTER WRITTEN
Thursday, January 19, 2017LETTER OF SUSPENSION E-MAILED
Thursday, January 19, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 20, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, July 9, 2018EXAMINER'S AMENDMENT ENTERED
Friday, July 21, 2017INQUIRY TO SUSPENSION E-MAILED
Friday, July 21, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 15, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 11, 2018NON-FINAL ACTION WRITTEN
Thursday, January 11, 2018NON-FINAL ACTION E-MAILED
Thursday, January 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 9, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, July 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 11, 2019SOU TEAS EXTENSION RECEIVED
Monday, July 9, 2018EXAMINERS AMENDMENT E-MAILED
Monday, July 9, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 13, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, July 17, 2018ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 20, 2019NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 4, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, April 11, 2019SOU EXTENSION 1 FILED
Thursday, April 11, 2019SOU EXTENSION 1 GRANTED
Saturday, April 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED